Remedium Bio is a Boston based gene therapy company focused on the development of highly innovative treatments for a broad range of diseases. The Remedium approach utilizes proven scientific fundamentals, in a novel way, to treat the most debilitating conditions. Starting with well-characterized pathophysiological principles, our scientists modularly apply proven technologies to quickly advance curative treatments through the R&D cycle. Today, our leading candidates include gene therapy treatments in the fields of Endocrinology, Cardiology, Hematology, and Rheumatology.
Location: United States, Massachusetts, Needham
Employees: 1-10
Total raised: $2.3M
Founded date: 2020
Investors 3
| Date | Name | Website |
| - | Angel Star... | angelstarv... |
| 01.12.2024 | SeedFolio | seedfolio.... |
| - | Longevityt... | longevityt... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.08.2022 | Seed | $2.3M | - |
Mentions in press and media 11
| Date | Title | Description |
| 10.08.2026 | Volta Infrastructure Raises $300M in Combined Seed and Series A Funding | Volta Infrastructure Holdings, a London, UK, Palo Alto, CA and New York City-based vertically integrated AI infrastructure platform and NVIDIA Cloud Partner, has emerged from stealth mode after securing $300m in combined Seed and Series A f... |
| 10.08.2026 | Remedium Bio Raises $10 Million Series A Led By Lifespan Vision Ventures With Participation From Eli Lilly And HKX Capital | Remedium Bio has raised $10 million in Series A financing led by Lifespan Vision Ventures to advance its durable protein therapeutics platform toward first-in-human clinical development. Eli Lilly and Company and HKX Capital also participat... |
| 10.08.2026 | Remedium Bio Raises $10M in Initial Series A Funding | Remedium Bio, Inc., a Needham, MA-based provider of a gene therapy platform developing durable protein therapeutics, raised $10M in initial Series A financing. The round was led by Lifespan Vision Ventures, with participation from Eli Lilly... |
| 24.09.2025 | LifeSpan Portfolio Company Remedium Signs Landmark Deal with Eli Lilly | NORWALK, Conn., Sept. 24, 2025 /PRNewswire/ -- Lifespan Vision Ventures is pleased to announce that its portfolio company, Remedium Bio, Inc. ("Remedium"), has entered into a multi-target research and development collaboration wit... |
| 12.09.2024 | A New Dawn in Gene Therapy: LifeSpan Vision Ventures Backs Remedium Bio | In the ever-evolving landscape of biotechnology, a new player is making waves. Remedium Bio, a Needham, Massachusetts-based company, has secured a significant investment from LifeSpan Vision Ventures. This partnership aims to propel Remediu... |
| 11.09.2024 | Remedium Bio Receives Investment from LifeSpan Vision Ventures | Remedium Bio, a Needham, MA-based biotechnology company focused on the development of treatments for large unmet clinical needs, received an investment from LifeSpan Vision Ventures. The amount of the deal was not disclosed. The company int... |
| 10.09.2024 | LifeSpan Vision Ventures Invests in Remedium Bio | NORWALK, Conn., Sept. 10, 2024 /PRNewswire/ -- LifeSpan Vision Ventures today announced that it has closed an investment in Remedium Bio. - The biotechnology company is developing a first-in-class adjustable-dose gene therapy platform calle... |
| 16.08.2022 | Remedium Bio Closes $2.3M Expanded Seed Funding | Remedium Bio, a Boston, MA-based biotechnology company, raised $2.3M in Expanded Seed funding. The round was led by Sherwood Ventures with participation from, LongevityTech.Fund, Primo Medical Group, Angel Star Ventures, Apis Health Angels,... |
| 15.08.2022 | Remedium Bio Announces $2.3M Expanded Seed raise | BOSTON, MA, Remedium Bioa biotechnology company developing, has closed more than $2.3M in its expanded seed round financing led by Sherwood Ventures. >> Click here for more funding data on Remedium Bio >> To export Remedium ... |
| 15.09.2021 | Remedium Bio announces research agreement with a leading Rheumatology laboratory |
Show more